Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Establishment and Characterization of a tel/abl Rearrangement Responsible for Imatinib Sensitivity in bcr/abl Negative Acute Lymphoblastic Leukemia.

Jörg Bäumler, PhD, J.H. Frederik Falkenburg, PhD, Marianke L.J. van Schie, Karoly Szuhai, PhD, Martine Pape, Sina Droll, Oliver G. Ottmann, PhD, Bart Nijmeijer, PhD

Blood (2007) 110 (11): 4280.

https://doi.org/10.1182/blood.V110.11.4280.4280

Published: 2007

Journal Articles

Rituximab and Alemtuzumab in Combination, but Not Alone, Induce Complete Remissions in a Preclinical Animal Model of Primary Human ALL: Rationale for Combination Treatment.

Bart Nijmeijer, PhD, Marianke L.J. van Schie, Roel Willemze, PhD, J.H. Frederik Falkenburg, PhD

Blood (2007) 110 (11): 2833.

https://doi.org/10.1182/blood.V110.11.2833.2833

Published: 2007

Journal Articles

Retroviral Gene Transfer of T Cell Receptors (TCR) Specific for Minor Histocompatibility Antigens to Virus-Specific T Cells as Cellular Immunotherapy of Patients with Relapsed Hematological Malignancies after Allogeneic Stem Cell Transplantation.

Marieke Griffioen, PhD, H.M. Esther van Egmond, Menno A.W.G. van der Hoorn, Renate S. Hagedoorn, Michel Kester, J.H. Frederik Falkenburg, PhD, MD, Mirjam H.M. Heemskerk, PhD

Blood (2005) 106 (11): 5529.

https://doi.org/10.1182/blood.V106.11.5529.5529

Published: 2005

Journal Articles

Identification of the Angiogenic Endothelial Cell Growth Factor-1/Thymidine Phosphorylase as a Target for Immunotherapy of Cancer.

Elisabeth H. Slager, PhD, M. Willy Honders, Edith D. van der Meijden, Simone A.P. van Luxemburg-Heijs, Freke M. Kloosterboer, PhD, Michel G.D. Kester, Inge Jedema, PhD, W.A. Erik Marijt, PhD, MD, M. Ronald Schaafsma, PhD, MD, J.H. Frederik Falkenburg, PhD, MD, Roel Willemze, PhD, MD

Blood (2005) 106 (11): 3094.

https://doi.org/10.1182/blood.V106.11.3094.3094

Published: 2005

Journal Articles

Toxicity and Effectivity of the Experimental Cytotoxic Drug Cyclopentenyl Cytosine in NOD/scid Mice with Acute Lymphoblastic Leukemia (ALL).

Kirsten J.M. Schimmel, PharmD, Bart A. Nijmeijer, PhD, Marianke L.J. van Schie, J.H. Frederik Falkenburg, PhD, Henk-Jan Guchelaar, PhD

Blood (2005) 106 (11): 4574.

https://doi.org/10.1182/blood.V106.11.4574.4574

Published: 2005

NARROW

Establishment and Characterization of a tel/abl Rearrangement Responsible for Imatinib Sensitivity in bcr/abl Negative Acute Lymphoblastic Leukemia.

Rituximab and Alemtuzumab in Combination, but Not Alone, Induce Complete Remissions in a Preclinical Animal Model of Primary Human ALL: Rationale for Combination Treatment.

Retroviral Gene Transfer of T Cell Receptors (TCR) Specific for Minor Histocompatibility Antigens to Virus-Specific T Cells as Cellular Immunotherapy of Patients with Relapsed Hematological Malignancies after Allogeneic Stem Cell Transplantation.

Identification of the Angiogenic Endothelial Cell Growth Factor-1/Thymidine Phosphorylase as a Target for Immunotherapy of Cancer.

Toxicity and Effectivity of the Experimental Cytotoxic Drug Cyclopentenyl Cytosine in NOD/scid Mice with Acute Lymphoblastic Leukemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

Establishment and Characterization of a tel/abl Rearrangement Responsible for Imatinib Sensitivity in bcr/abl Negative Acute Lymphoblastic Leukemia.

Rituximab and Alemtuzumab in Combination, but Not Alone, Induce Complete Remissions in a Preclinical Animal Model of Primary Human ALL: Rationale for Combination Treatment.

Retroviral Gene Transfer of T Cell Receptors (TCR) Specific for Minor Histocompatibility Antigens to Virus-Specific T Cells as Cellular Immunotherapy of Patients with Relapsed Hematological Malignancies after Allogeneic Stem Cell Transplantation.

Identification of the Angiogenic Endothelial Cell Growth Factor-1/Thymidine Phosphorylase as a Target for Immunotherapy of Cancer.

Toxicity and Effectivity of the Experimental Cytotoxic Drug Cyclopentenyl Cytosine in NOD/scid Mice with Acute Lymphoblastic Leukemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only